Merck (MRK) Long-Term Debt Repayments (2009 - 2026)

Merck (MRK) has reported Long-Term Debt Repayments for 17 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Long-Term Debt Repayments changed N/A year-over-year to $5.0 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 62.22% decrease from a year earlier, with the FY2025 full-year figure at $2.5 billion, up 94.03% from the prior year.
• Long-Term Debt Repayments was $5.0 million for Q2 2026 at Merck, down from $1.1 billion in the prior quarter.
• Over five years, Long-Term Debt Repayments peaked at $2.5 billion in Q1 2025 and troughed at $1.0 million in Q4 2022.
• A 5-year average of $638.9 million and a median of $272.0 million in 2024 frame the typical range for Long-Term Debt Repayments.
• Across the five-year window, Long-Term Debt Repayments plunged 99.92% in 2023 and soared 75000.0% in 2024, its largest moves.
• Over 5 years, Long-Term Debt Repayments stood at $1.0 million in 2022, then soared by 200.0% to $3.0 million in 2023, then surged by 17866.67% to $539.0 million in 2024, then plunged by 99.63% to $2.0 million in 2025, then jumped by 150.0% to $5.0 million in 2026.
• The last three Long-Term Debt Repayments figures came in at $5.0 million (Q2 2026), $1.1 billion (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.